6th EURETINA Congress Lisbon 2006



PROGRAMME OVERVIEW
SCIENTIFIC SESSIONS
SPAIN/SOUTH AMERICA & PORTUGAL/BRAZIL SYMPOSIA
NETWORKING SESSIONS
PRIMARY RETINAL DETACHMENT COURSE
FREE PAPER SESSIONS
POSTER PRESENTATIONS
CONTINUOUS VIDEO PROGRAMME
SATELLITE PROGRAMME



	Free Papers Session Presentations are 6 minutes in duration, followed by 2 minutes discussion New Therapies Of AMD III Friday 19 May 1700 - 1800 AuditoriumII
		L. Arias, M. Rubio, J. Caminal, O. Pujol, SPAIN Photodynamic therapy with intravitreal triamcinolone in predominantly classic choroidal neovascularization: One-year results of a randomized study
		U. Introini, M. Setaccioli, M. Gagliardi, A. Ramoni, F. Scotti, R. Brancato, ITALY Intravitreal Triamcinolone Acetonide (IVTA) injection alone or combined with PDT for vascularized retinal pigment epithelial detachments (V-PED) in AMD
		M. Nicolo, D. Ghiglione, G. Calabria, ITALY Occult with no classic choroidal neovascularization secondary to age-related macular degeneration treated by intravitreal triamcinolone and photodynamic therapy with verteporfin
		J.M. Ruiz-Moreno, J.A. Montero-Moreno, SPAIN Photodynamic therapy and high dose intravitreal triamcinolone to treat exudative age-related macular degeneration: Two years outcome
		G. Soubrane, P. Haymann, FRANCE Verteporfin PDT for occult with no classic CNV in AMD: 12-month results of the PDT in Occult-Only Lesions (POOL) Study
		P. Talty, D. Kilmartin, IRELAND Predictive value of one week assessment for long term outcome after first photodynamic therapy (PDT)
		T. Hadjistilianou, S. De Francesco, F. Menicacci, A. Cerase, ITALY Malignant transformation of retinocytoma: Successful conservative treatment